FT Health: Combating Coronavirus

As the pandemic puts the spotlight on drug companies, we report on CEOs’ calls for government support, and ask how Big Pharma can reconcile IP with the need for collaboration. From April 28: manufacturing challenges and the threat from anti-vaxxers